Cargando…

Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide with poor prognosis. However, its prognostic evaluation is still an urgent problem. The objectives of this present study were to investigate oncofetal antigen glypican-3 (GPC-3) expression in HCC and their match para-can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Li, Pan, Liuhong, Yao, Min, Cai, Yin, Dong, Zhizhen, Yao, Dengfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173123/ https://www.ncbi.nlm.nih.gov/pubmed/27286460 http://dx.doi.org/10.18632/oncotarget.9892

Ejemplares similares

Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis
por: Sai, Wenli, et al.
Publicado: (2015)

Oncogenic Wnt3a: A Candidate Specific Marker and Novel Molecular Target for Hepatocellular Carcinoma
por: Zheng, Wenjie, et al.
Publicado: (2019)

Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma.
por: Starzynska, T., et al.
Publicado: (1994)

High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma
por: Zheng, Wenjie, et al.
Publicado: (2018)

Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
por: Wang, Li, et al.
Publicado: (2013)

Targeted glypican-3 gene transcription inhibited the proliferation of human hepatoma cells by specific short hairpin RNA
por: Yu, Dandan, et al.
Publicado: (2012)

Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis
por: Zhang, Jian, et al.
Publicado: (2018)

Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis
por: Xiao, Wei-Kai, et al.
Publicado: (2014)

Identification and functional characterization of potential oncofetal targets in human hepatocellular carcinoma
por: Li, Mei-Mei, et al.
Publicado: (2022)

High glypican-1 expression is a prognostic factor for predicting a poor clinical prognosis in patients with hepatocellular carcinoma
por: Chen, Guoyong, et al.
Publicado: (2020)

Plasmodium parasite as an effective hepatocellular carcinoma antigen glypican-3 delivery vector
por: Liu, Quan, et al.
Publicado: (2017)

Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis
por: Liu, Hong, et al.
Publicado: (2018)

Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma
por: Hara, Hisashi, et al.
Publicado: (2016)

Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
por: Kaseb, Ahmed Omar, et al.
Publicado: (2016)

Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas
por: El-Saadany, Sherif, et al.
Publicado: (2018)

Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
por: Nishida, Takahiro, et al.
Publicado: (2019)

Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target
por: Zheng, Wenjie, et al.
Publicado: (2016)

Tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling?
por: David, L.
Publicado: (1996)

Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma
por: Wang, Jian-Yao, et al.
Publicado: (2021)

Oncofetal antigen/immature laminin receptor protein in pregnancy and cancer
por: Barsoum, Adel L., et al.
Publicado: (2014)

Expression of Oncofetal Antigen 5T4 in Murine Taste Papillae
por: Takahashi, Yuka, et al.
Publicado: (2019)

SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma
por: Zhang, Xin, et al.
Publicado: (2015)

Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma
por: Sun, Luan, et al.
Publicado: (2021)

Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis
por: Sun, Bin, et al.
Publicado: (2017)

Interaction of the Oncofetal Thomsen–Friedenreich Antigen with Galectins in Cancer Progression and Metastasis
por: Sindrewicz, Paulina, et al.
Publicado: (2016)

The oncofetal protein IMP3 is an indicator of early recurrence and poor outcome in mucoepidermoid carcinoma of salivary glands
por: Elshafey, Mohamed R., et al.
Publicado: (2016)

Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma
por: Chen, Peng, et al.
Publicado: (2019)

Diagnostic accuracy and prognostic significance of Glypican-3 in hepatocellular carcinoma: A systematic review and meta-analysis
por: Jiang, Donglei, et al.
Publicado: (2022)

Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis
por: Yang, Shanshan, et al.
Publicado: (2022)

Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma
por: Bell, Meghan M., et al.
Publicado: (2020)

Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis
por: Zhou, Hua, et al.
Publicado: (2018)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen
por: Harrop, Richard, et al.
Publicado: (2019)

Dysplastic Nodules with Glypican-3 Positive Immunostaining: A Risk for Early Hepatocellular Carcinoma
por: Gong, Li, et al.
Publicado: (2014)

Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release
por: Liu, Xuan, et al.
Publicado: (2020)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
por: Zheng, Ye, et al.
Publicado: (2022)

Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: A prospective study
por: Hamaoka, Michinori, et al.
Publicado: (2019)

Expression Characteristics of Hypoxia-Inducible Factor-1α and Its Clinical Values in Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Li, Shanshan, et al.
Publicado: (2011)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection
por: Zhang, Xia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4nuukb78us2ss7dpqgd4mcuhk1